Susumu Maruta
发表
N. Kato,
T. Kanda,
S. Nakamoto,
2020,
International journal of medical sciences.
N. Kato,
T. Kanda,
M. Arai,
2019,
Journal of Hepatology.
S. Nakamoto,
R. Muroyama,
R. Nakagawa,
2022,
Cancer.
S. Nakamoto,
T. Chiba,
Naoya Kanogawa,
2022,
Hepatology research : the official journal of the Japan Society of Hepatology.
A. Iwama,
N. Kato,
Y. Zen,
2021,
Scientific Reports.
N. Sugiura,
N. Kato,
T. Kanda,
2020,
Liver Cancer.
N. Sugiura,
N. Kato,
T. Kanda,
2019,
Investigational New Drugs.
M. Arai,
Y. Takiguchi,
A. Tawada,
2019,
International Cancer Conference Journal.
Jun Kato,
N. Kato,
M. Arai,
2020,
Clinical and molecular hepatology.
N. Sugiura,
N. Kato,
T. Kanda,
2021,
Liver Cancer.
N. Kato,
S. Okabe,
M. Arai,
2021
.
Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
N. Kato,
T. Kanda,
S. Nakamoto,
2019,
BMC Cancer.
M. Miyazaki,
O. Yokosuka,
N. Kato,
2020,
Liver Cancer.
S. Nakamoto,
R. Muroyama,
R. Nakagawa,
2023,
BMC Gastroenterology.
S. Nakamoto,
R. Muroyama,
R. Nakagawa,
2023,
BMC Gastroenterology.
O. Yokosuka,
N. Kato,
T. Kanda,
2020,
JGH open : an open access journal of gastroenterology and hepatology.
T. Kanda,
M. Arai,
S. Nakamoto,
2020,
Journal of Hepatology.
Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
N. Kato,
T. Kanda,
S. Nakamoto,
2019,
BMC Cancer.
I. Yoshino,
N. Kato,
T. Kishimoto,
2021,
Kanzo.
Y. Koshima,
Susumu Maruta,
Takahiro Tsuchiya,
2024,
Cureus.